Brandtree

Who owns Doril?

Doril is owned by Hypera (Brazil, B3: HYPE3).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026), 18 June 2026. Last checked .

Key facts

Current owner
Hypera Pharma reported
Owner HQ
🇧🇷 Brazil, São Paulo
Origin
🇧🇷 Brazil
Category
Consumer health › Over-the-counter medicine › Pain relief
Parent ticker
B3: HYPE3
Last verified
· 1 sources

About Doril

Doril is a Hypera Pharma painkiller and fever reducer known by the slogan "Tomou Doril, a dor sumiu" ("Took Doril, the pain went away"). The range covers standard Doril tablets for pain, fever and headache, Doril Enxaqueca for migraine and period pain, and Doril Pro for inflammatory pain such as sore throat, back pain and tendinitis.

Ownership timeline of Doril

  1. Current owner Hypera [1] reported

Where Doril sits in Hypera

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Doril sits in Hypera Tree of 8 brands under Hypera. Hypera Doril Benegrip Biotônico Fontoura Engov Epocler Estomazil and 2 more

Open the full Hypera ownership tree →

See the full Hypera brand portfolio (8) →

Other brands owned by Hypera

Hypera controls 8 brands on Brandtree, 5 of them in consumer health.

Also in consumer health

All Hypera brands →

Other brands in pain relief, and who owns them

The 37 brands in pain relief on Brandtree belong to 21 owners. The largest is Haleon, with 3; Hypera has 2.

BrandOwnerOwner based in
Advil Haleon 🇬🇧 United Kingdom
Air Salonpas Hisamitsu Pharmaceutical 🇯🇵 Japan
Motrin Kenvue 🇺🇸 United States
Dafalgan Taisho Pharmaceutical 🇯🇵 Japan
Nicotex Cipla 🇮🇳 India
Mentho Plus Emami 🇮🇳 India
Bufferin (United States) Genomma Lab 🇲🇽 Mexico
Daleron Krka 🇸🇮 Slovenia

Every brand in pain relief and its owner →

About the owner: Hypera

Hypera is a publicly listed company headquartered in São Paulo, Brazil, founded in 2001. Brandtree records 8 brands under its control, and it is listed as B3: HYPE3.

Hypera Pharma is a Brazilian pharmaceutical company that began operating in December 2001 as a consumer goods business and moved into medicines in 2007, selling its cosmetics and disposables operations in 2015 and 2017. It leads the Brazilian over-the-counter medicines market and has been listed on B3's Novo Mercado since 2008. Votorantim S.A. joined its controlling shareholder group in 2025.

Hypera: full profile, brands and acquisition history →

🇧🇷 Doril and other Brazilian brands

Brandtree records a controlling owner for 177 brands that began in Brazil. 32 of them (18%) are now controlled by a company headquartered in another country; Doril is not one of them.

All Brazilian brands and who owns them →

Frequently asked questions

Who is the parent company of Doril?

The parent company of Doril is Hypera, a publicly listed company headquartered in Brazil.

Is Doril Brazilian?

Yes. Doril originated in Brazil and its owner, Hypera, is also headquartered in Brazil.

Is Doril still owned by Hypera?

Yes. As of 16 September 2026, Doril is still owned by Hypera. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.